Protein kinase CK2-dependent phosphorylation of the human Regulators of Calcineurin reveals a novel mechanism regulating the calcineurin-NFATc signaling pathway

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1833, Issue 10, 2013, Pages 2311-2321

  Martínez Høyer, Sergio ^a   Aranguren Ibáñez, Álvaro ^a   García García, Javier ^b   Serrano Candelas, Eva ^a   Vilardell, Jordi ^c   Nunes, Virginia ^d   Aguado, Fernando ^d   Oliva, Baldo ^b   Itarte, Emilio ^c   Pérez Riba, Mercè ^a  

^a BELLVITGE BIOMEDICAL RESEARCH INSTITUTE IDIBELL   (Spain)

^b UNIVERSITAT POMPEU FABRA   (Spain)

^c UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^d UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Calcineurin NFATc signaling; CK2; Immunosuppression; Phosphorylation; PXIXIT; RCAN

Indexed keywords

CALCINEURIN; CASEIN KINASE II; TRANSCRIPTION FACTOR NFAT;

ARTICLE; EMBRYO; GENE EXPRESSION; HUMAN; HUMAN CELL; MOLECULAR INTERACTION; MOLECULAR MECHANICS; MOLECULAR MODEL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

CALCINEURIN; CALCINEURIN CATALYTIC SUBUNIT A; CALCINEURIN-NFATC SIGNALING; CIC SEQUENCE; CK2; CN; CNA; CSA; CYCLOSPORIN A; CYTOSOLIC NUCLEAR FACTOR OF ACTIVATED T-CELLS; IMMUNOSUPPRESSION; IO; IONOMYCIN; NFATC; PHORBOL 12-MIRISTATE 13-ACETATE; PHOSPHORYLATION; PMA; PROTEIN KINASE CK2; PXIXIT; RCAN; RCAN (FORMERLY CALCIPRESSIN) INHIBITOR OF CALCINEURIN SEQUENCE; REGULATORS OF CALCINEURIN;

AMINO ACID SEQUENCE; BLOTTING, WESTERN; CALCINEURIN; CASEIN KINASE II; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; CIRCULAR DICHROISM; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION; HUMANS; IMMUNOPRECIPITATION; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LUCIFERASES; MOLECULAR SEQUENCE DATA; MUSCLE PROTEINS; NFATC TRANSCRIPTION FACTORS; PHOSPHORYLATION; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SEQUENCE HOMOLOGY, AMINO ACID; SIGNAL TRANSDUCTION;

VERTEBRATA;

EID: 84879710786     PISSN: 01674889     EISSN: 18792596     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2013.05.021     Document Type: Article

References (42)

1. Aramburu J., Rao A., Klee C.B. Calcineurin: from structure to function. Curr. Top. Cell. Regul. 2000, 36:237-295.
2. Rao A. Signaling to gene expression: calcium, calcineurin and NFAT. Nat. Immunol. 2009, 10:3-5.
3. Wu H., Peisley A., Graef I.A., Crabtree G.R. NFAT signaling and the invention of vertebrates. Trends Cell Biol. 2007, 17:251-260.
4. Liu J., Farmer J.D., Lane W.S., Friedman J., Weissman I., Schreiber S.L. Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell 1991, 66:807-815.
5. Martinez-Martinez S., Redondo J.M. Inhibitors of the calcineurin/NFAT pathway. Curr. Med. Chem. 2004, 11:997-1007.
6. Fuentes J.J., Genesca L., Kingsbury T.J., Cunningham K.W., Perez-Riba M., Estivill X., de la Luna S. DSCR1, overexpressed in Down syndrome, is an inhibitor of calcineurin-mediated signaling pathways. Hum. Mol. Genet. 2000, 9:1681-1690.
7. Kingsbury T.J., Cunningham K.W. A conserved family of calcineurin regulators. Genes Dev. 2000, 14:1595-1604.
8. Mulero M.C., Aubareda A., Schluter A., Perez-Riba M. RCAN3, a novel calcineurin inhibitor that down-regulates NFAT-dependent cytokine gene expression. Biochim. Biophys. Acta 2007, 1773:330-341.
9. Davies K.J., Ermak G., Rothermel B.A., Pritchard M., Heitman J., Ahnn J., Henrique-Silva F., Crawford D., Canaider S., Strippoli P., Carinci P., Min K.T., Fox D.S., Cunningham K.W., Bassel-Duby R., Olson E.N., Zhang Z., Williams R.S., Gerber H.P., Perez-Riba M., Seo H., Cao X., Klee C.B., Redondo J.M., Maltais L.J., Bruford E.A., Povey S., Molkentin J.D., McKeon F.D., Duh E.J., Crabtree G.R., Cyert M.S., de la Luna S., Estivill X. Renaming the DSCR1/Adapt78 gene family as RCAN: regulators of calcineurin. FASEB J. 2007, 21:3023-3028.
10. Garcia-Cozar F.J., Okamura H., Aramburu J.F., Shaw K.T., Pelletier L., Showalter R., Villafranca E., Rao A. Two-site interaction of nuclear factor of activated T cells with activated calcineurin. J. Biol. Chem. 1998, 273:23877-23883.
11. Aramburu J., Garcia-Cozar F., Raghavan A., Okamura H., Rao A., Hogan P.G. Selective inhibition of NFAT activation by a peptide spanning the calcineurin targeting site of NFAT. Mol. Cell 1998, 1:627-637.
12. Mulero M.C., Aubareda A., Orzaez M., Messeguer J., Serrano-Candelas E., Martinez-Hoyer S., Messeguer A., Perez-Paya E., Perez-Riba M., Orzáez M., Martínez-Hoyer S., Pérez-Payá E., Pérez-Riba M. Inhibiting the calcineurin-NFAT (nuclear factor of activated T cells) signaling pathway with a regulator of calcineurin-derived peptide without affecting general calcineurin phosphatase activity. J. Biol. Chem. 2009, 284:9394-9401.
13. Mehta S., Li H., Hogan P.G., Cunningham K.W. Domain architecture of the regulators of calcineurin (RCANs) and identification of a divergent RCAN in yeast. Mol. Cell. Biol. 2009, 29:2777-2793.
14. Martinez-Martinez S., Genesca L., Rodriguez A., Raya A., Salichs E., Were F., Lopez-Maderuelo M.D., Redondo J.M., de la Luna S. The RCAN carboxyl end mediates calcineurin docking-dependent inhibition via a site that dictates binding to substrates and regulators. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:6117-6122.
15. Roy J., Cyert M.S. Cracking the phosphatase code: docking interactions determine substrate specificity. Sci. Signal. 2009, 2:re9.
16. Aramburu J., Yaffe M.B., López-Rodríguez C., Cantley L.C., Hogan P.G., Rao A. Affinity-driven peptide selection of an NFAT inhibitor more selective than cyclosporin A. Science 1999, 285:2129-2133.
17. Li H., Zhang L., Rao A., Harrison S.C., Hogan P.G. Structure of calcineurin in complex with PVIVIT peptide: portrait of a low-affinity signalling interaction. J. Mol. Biol. 2007, 369:1296-1306.
18. Roy J., Li H., Hogan P.G., Cyert M.S. A conserved docking site modulates substrate affinity for calcineurin, signaling output, and in vivo function. Mol. Cell 2007, 25:889-901.
19. Muller M.R., Sasaki Y., Stevanovic I., Lamperti E.D., Ghosh S., Sharma S., Gelinas C., Rossi D.J., Pipkin M.E., Rajewsky K., Hogan P.G., Rao A., Müller M.R. Requirement for balanced Ca/NFAT signaling in hematopoietic and embryonic development. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:7034-7039.
20. Li H., Pink M., Murphy J., Stein A., Dell'acqua M., Hogan P.G. Balanced interactions of calcineurin with AKAP79 regulate Ca(2+)-calcineurin-NFAT signaling. Nat. Struct. Mol. Biol 2012, 19:337-345.
21. Aubareda A., Mulero M.C., Perez-Riba M. Functional characterization of the calcipressin 1 motif that suppresses calcineurin-mediated NFAT-dependent cytokine gene expression in human T cells. Cell. Signal. 2006, 18:1430-1438.
22. Ryeom S., Greenwald R.J., Sharpe A.H., McKeon F. The threshold pattern of calcineurin-dependent gene expression is altered by loss of the endogenous inhibitor calcipressin. Nat. Immunol. 2003, 4:874-881.
23. Hilioti Z., Gallagher D.A., Low-Nam S.T., Ramaswamy P., Gajer P., Kingsbury T.J., Birchwood C.J., Levchenko A., Cunningham K.W. GSK-3 kinases enhance calcineurin signaling by phosphorylation of RCNs. Genes Dev. 2004, 18:35-47.
24. Sanna B., Brandt E.B., Kaiser R.A., Pfluger P., Witt S.A., Kimball T.R., van Rooij E., De Windt L.J., Rothenberg M.E., Tschop M.H., Benoit S.C., Molkentin J.D. Modulatory calcineurin-interacting proteins 1 and 2 function as calcineurin facilitators in vivo. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:7327-7332.
25. Vega R.B., Yang J., Rothermel B.A., Bassel-Duby R., Williams R.S. Multiple domains of MCIP1 contribute to inhibition of calcineurin activity. J. Biol. Chem. 2002, 277:30401-30407.
26. Genesca L., Aubareda A., Fuentes J.J., Estivill X., De La Luna S., Perez-Riba M. Phosphorylation of calcipressin 1 increases its ability to inhibit calcineurin and decreases calcipressin half-life. Biochem. J. 2003, 374:567-575.
27. Abbasi S., Lee J.D., Su B., Chen X., Alcon J.L., Yang J., Kellems R.E., Xia Y. Protein kinase-mediated regulation of calcineurin through the phosphorylation of modulatory calcineurin-interacting protein 1. J. Biol. Chem. 2006, 281:7717-7726.
28. Jung M.S., Park J.H., Ryu Y.S., Choi S.H., Yoon S.H., Kwen M.Y., Oh J.Y., Song W.J., Chung S.H. Regulation of RCAN1 protein activity by Dyrk1A protein-mediated phosphorylation. J. Biol. Chem. 2011, 286:40401-40412.
29. Liu Q., Busby J.C., Molkentin J.D. Interaction between TAK1-TAB1-TAB2 and RCAN1-calcineurin defines a signalling nodal control point. Nat. Cell Biol. 2009, 11:154-161.
30. Kim S.S., Oh Y., Chung K.C., Seo S.R. Protein kinase A phosphorylates Down syndrome critical region 1 (RCAN1). Biochem. Biophys. Res. Commun. 2012, 418:657-661.
31. Meggio F., Pinna L.A. One-thousand-and-one substrates of protein kinase CK2?. FASEB J. 2003, 17:349-368.
32. Porter C.M., Havens M.A., Clipstone N.A. Identification of amino acid residues and protein kinases involved in the regulation of NFATc subcellular localization. J. Biol. Chem. 2000, 275:3543-3551.
33. Pinna L.A. Protein kinase CK2: a challenge to canons. J. Cell Sci. 2002, 115:3873-3878.
34. Montenarh M. Cellular regulators of protein kinase CK2. Cell Tissue Res. 2010, 342:139-146.
35. Berman H.M., Westbrook J., Feng Z., Gilliland G., Bhat T.N., Weissig H., Shindyalov I.N., Bourne P.E. The Protein Data Bank. Nucleic Acids Res. 2000, 28:235-242.
36. Eswar N., Webb B., Marti-Renom M.A., Madhusudhan M.S., Eramian D., Shen M.-Y., Pieper U., Sali A. Comparative protein structure modeling using MODELLER. Curr. Protoc. Protein Sci. 2007, 50:2.9.1-2.9.31.
37. Pierce B., Weng Z. ZRANK: reranking protein docking predictions with an optimized energy function. Proteins 2007, 67:1078-1086.
38. Schrodinger L.L.C. The PyMOL Molecular Graphics System, Version 13r1 2010.
39. Baker N.A., Sept D., Joseph S., Holst M.J., McCammon J.A. Electrostatics of nanosystems: application to microtubules and the ribosome. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:10037-10041.
40. Blom N., Gammeltoft S., Brunak S. Sequence and structure-based prediction of eukaryotic protein phosphorylation sites. J. Mol. Biol. 1999, 294:1351-1362.
41. Salvi M., Trashi E., Cozza G., Negro A., Hanson P.I., Pinna L.A. Tools to discriminate between targets of CK2 vs PLK2/PLK3 acidophilic kinases. Biotechniques 2012, 2012.
42. Battistutta R., Cozza G., Pierre F., Papinutto E., Lolli G., Sarno S., O'Brien S.E., Siddiqui-Jain A., Haddach M., Anderes K., Ryckman D.M., Meggio F., Pinna L.A. Unprecedented selectivity and structural determinants of a new class of protein kinase CK2 inhibitors in clinical trials for the treatment of cancer. Biochemistry 2011, 50:8478-8488.